Biomedical research at Oslo University Hospital
Oslo University Hospital is a merger of three former university hospitals in Oslo. Biomedical research is one of the hospital's core activities. Research at the hospital is closely interlinked with research undertaken at the University of Oslo. More than 50% of all biomedical research in Norway is published by researchers affiliated with the hospital. Research undertaken cover both basic research, translational research, and clinical research.
Oslo University Hospital has a central role in developing and supporting biomedical research within the South-Eastern Regional Health Authority. The hospital also pursues international research collaborations.
Click here to see hierarchical division and subunit overview
Summary of publications:
Publications (original articles or review articles) published in 2021 from OUS - Division of Paediatric and Adolescent Medicine
12 publications found
Primary antibody deficiency: the impact on the quality of life and mental health of affected children and their parents
Acta Paediatr (in press)
DOI 10.1111/apa.15752, PubMed 33420742
Prevalence of long-term mechanical insufflation-exsufflation in children with neurological conditions: a population-based study
Dev Med Child Neurol (in press)
DOI 10.1111/dmcn.14797, PubMed 33393110
Brain MR patterns in inherited disorders of monoamine neurotransmitters: An analysis of 70 patients
J Inherit Metab Dis (in press)
DOI 10.1002/jimd.12360, PubMed 33443316
Hip pain in adolescents with cerebral palsy: a population-based longitudinal study
Dev Med Child Neurol (in press)
DOI 10.1111/dmcn.14782, PubMed 33393085
50 Years Ago in TheJournalofPediatrics: The Newborn Electrocardiogram
J Pediatr, 228, 52
DOI 10.1016/j.jpeds.2020.07.074, PubMed 33342502
Therapy-induced Deletion in 11q23 Leading to Fusion of KMT2A With ARHGEF12 and Development of B Lineage Acute Lymphoplastic Leukemia in a Child Treated for Acute Myeloid Leukemia Caused by t(9;11)(p21;q23)/KMT2A-MLLT3
Cancer Genomics Proteomics, 18 (1), 67-81
DOI 10.21873/cgp.20242, PubMed 33419897
Expression of immunoreactive inducible nitric oxide synthase in pancreatic islet cells from newly diagnosed and long-term type 1 diabetic donors is heterogeneous and not disease-associated
Cell Tissue Res (in press)
DOI 10.1007/s00441-020-03340-4, PubMed 33427953
One in Ten CD8+ Cells in the Pancreas of Living Individuals With Recent Onset Type 1 Diabetes Recognizes the Preproinsulin Epitope PPI15-24
Diabetes (in press)
DOI 10.2337/db20-0908, PubMed 33414250
Serum Galectin-3 and Subsequent Risk of Coronary Heart Disease in Subjects With Childhood-Onset Type 1 Diabetes: A Cohort Study
Diabetes Care (in press)
DOI 10.2337/dc20-1712, PubMed 33408220
NF-κB activity during pancreas development regulates adult β-cell mass by modulating neonatal β-cell proliferation and apoptosis
Cell Death Discov, 7 (1), 2
DOI 10.1038/s41420-020-00386-9, PubMed 33414444
Maintaining human milk bank services throughout the COVID-19 pandemic: A global response
Matern Child Nutr, e13131 (in press)
DOI 10.1111/mcn.13131, PubMed 33403779
Effects of nutrition therapy on growth, inflammation and metabolism in immature infants: a study protocol of a double-blind randomized controlled trial (ImNuT)
BMC Pediatr, 21 (1), 19
DOI 10.1186/s12887-020-02425-x, PubMed 33407269